Hansa Biopharma AB (HNSA) — Tangible Net Worth Ratio
Hansa Biopharma AB (HNSA) has a Tangible Net Worth Ratio of 47.3% as of June 2023. This metric is calculated by deducting intangible assets (Skr95.94 Million) from net assets (Skr182.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Hansa Biopharma AB net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hansa Biopharma AB Tangible Net Worth Ratio (2008–2022)
This chart shows how Hansa Biopharma AB's Tangible Net Worth Ratio has changed across 15 annual periods from 2008 to 2022. As of June 2023, the ratio stands at 47.3%, reflecting net assets of Skr182.18 Million with intangible assets of Skr95.94 Million SEK. For live market cap and overall valuation, see market cap of Hansa Biopharma AB.
Annual Tangible Net Worth Ratio for Hansa Biopharma AB (2008–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Hansa Biopharma AB from 2008 to 2022, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore HNSA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 92.2% | Skr602.91 Million | Skr46.87 Million | Skr1.69 Billion | ▼ -4.0 pp |
| 2021 | 96.2% | Skr757.57 Million | Skr28.76 Million | Skr1.01 Billion | ▼ -1.3 pp |
| 2020 | 97.5% | Skr1.24 Billion | Skr31.41 Million | Skr1.43 Billion | ▲ +3.4 pp |
| 2019 | 94.1% | Skr562.82 Million | Skr33.35 Million | Skr664.24 Million | ▼ -2.1 pp |
| 2018 | 96.1% | Skr859.88 Million | Skr33.20 Million | Skr944.82 Million | ▲ +1.5 pp |
| 2017 | 94.6% | Skr630.66 Million | Skr33.75 Million | Skr680.41 Million | ▲ +7.5 pp |
| 2016 | 87.1% | Skr283.69 Million | Skr36.55 Million | Skr310.67 Million | ▲ +4.3 pp |
| 2015 | 82.8% | Skr211.53 Million | Skr36.33 Million | Skr224.09 Million | ▲ +56.9 pp |
| 2014 | 25.9% | Skr49.80 Million | Skr36.90 Million | Skr54.31 Million | ▲ +14.4 pp |
| 2013 | 11.5% | Skr45.68 Million | Skr40.42 Million | Skr50.78 Million | ▼ -24.7 pp |
| 2012 | 36.2% | Skr63.24 Million | Skr40.37 Million | Skr65.80 Million | ▼ -60.4 pp |
| 2011 | 96.6% | Skr34.71 Million | Skr1.19 Million | Skr40.90 Million | ▼ -0.6 pp |
| 2010 | 97.2% | Skr32.17 Million | Skr898.50K | Skr37.80 Million | ▼ -2.8 pp |
| 2009 | 100.0% | Skr24.92 Million | Skr0.00 | Skr38.15 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Skr40.73 Million | Skr0.00 | Skr44.87 Million | — |